{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:27:19Z","timestamp":1793654839142,"version":"4.5.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1038\/s41440-025-02351-4","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T04:13:47Z","timestamp":1756095227000},"page":"2841-2853","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prospective study of primary aldosteronism in acute ischemic stroke: association with small vessel disease"],"prefix":"10.1038","volume":"48","author":[{"given":"Motohiro","family":"Okumura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Tsujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Yamashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Gomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideto","family":"Kuribayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teppei","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Sakuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Mitsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"2351_CR1","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","volume":"9","author":"M Reincke","year":"2021","unstructured":"Reincke M, Bancos I, Mulatero P, Scholl UI, Stowasser M, Williams TA. Diagnosis and treatment of primary aldosteronism. Lancet Diabetes Endocrinol. 2021;9:876\u201392.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2351_CR2","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/s41440-023-01288-w","volume":"46","author":"Y Yoshida","year":"2023","unstructured":"Yoshida Y, Shibata H. Recent progress in the diagnosis and treatment of primary aldosteronism. Hypertens Res. 2023;46:1738\u201344.","journal-title":"Hypertens Res"},{"key":"2351_CR3","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-016-0701-5","volume":"16","author":"Y Miyaji","year":"2016","unstructured":"Miyaji Y, Kawabata Y, Joki H, Seki S, Mori K, Kamide T, et al. Primary aldosteronism in patients with acute stroke: prevalence and diagnosis during initial hospitalization. BMC Neurol. 2016;16:177.","journal-title":"BMC Neurol"},{"key":"2351_CR4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116774","volume":"413","author":"Z Tang","year":"2020","unstructured":"Tang Z, Chen H, He W, Ma L, Song Y, Mei M, et al. Primary aldosteronism in young adults with acute stroke: prevalence and clinical characteristics. J Neurol Sci. 2020;413:116774.","journal-title":"J Neurol Sci"},{"key":"2351_CR5","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.869980","volume":"13","author":"V Nguyen","year":"2022","unstructured":"Nguyen V, Tu TM, Mamauag MJB, Lai J, Saffari SE, Aw TC, et al. Primary aldosteronism more prevalent in patients with cardioembolic stroke and atrial fibrillation. Front Endocrinol. 2022;13:869980.","journal-title":"Front Endocrinol"},{"key":"2351_CR6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1590\/2359-3997000000274","volume":"61","author":"LAP Vilela","year":"2017","unstructured":"Vilela LAP, Almeida MQ. Diagnosis and management of primary aldosteronism. Arch Endocrinol Metab. 2017;61:305\u201312.","journal-title":"Arch Endocrinol Metab"},{"key":"2351_CR7","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/jclinpath-2017-204423","volume":"70","author":"G Kline","year":"2017","unstructured":"Kline G, Holmes DT. Adrenal venous sampling for primary aldosteronism: laboratory medicine best practice. J Clin Pathol. 2017;70:911.","journal-title":"J Clin Pathol"},{"key":"2351_CR8","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1097\/HJH.0000000000001855","volume":"36","author":"H Kobayashi","year":"2018","unstructured":"Kobayashi H, Abe M, Soma M, Takeda Y, Kurihara I, Itoh H, et al. Development and validation of subtype prediction scores for the workup of primary aldosteronism. J Hypertens. 2018;36:2269\u201376.","journal-title":"J Hypertens"},{"key":"2351_CR9","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1210\/jc.2018-00866","volume":"103","author":"Y Ohno","year":"2018","unstructured":"Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, et al. Obesity as a key factor underlying idiopathic hyperaldosteronism. J Clin Endocrinol Metab. 2018;103:4456\u201364.","journal-title":"J Clin Endocrinol Metab"},{"key":"2351_CR10","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/HYPERTENSIONAHA.114.05001","volume":"65","author":"T Matsumoto","year":"2015","unstructured":"Matsumoto T, Oki K, Kajikawa M, Nakashima A, Maruhashi T, Iwamoto Y, et al. Effect of aldosterone-producing adenoma on endothelial function and rho-associated kinase activity in patients with primary aldosteronism. Hypertension. 2015;65:841\u20138.","journal-title":"Hypertension"},{"key":"2351_CR11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/s41440-023-01481-x","volume":"47","author":"T Haze","year":"2024","unstructured":"Haze T, Tamura K. Possible relationship between primary aldosteronism and small vessel disease. Hypertens Res. 2024;47:677\u20138.","journal-title":"Hypertens Res"},{"key":"2351_CR12","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1007\/s00415-018-9077-3","volume":"266","author":"X Chen","year":"2019","unstructured":"Chen X, Wang J, Shan Y, Cai W, Liu S, Hu M, et al. Cerebral small vessel disease: neuroimaging markers and clinical implication. J Neurol. 2019;266:2347\u201362.","journal-title":"J Neurol"},{"key":"2351_CR13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3390\/diagnostics11030433","volume":"11","author":"Y Ozeki","year":"2021","unstructured":"Ozeki Y, Tanimura Y, Nagai S, Nomura T, Kinoshita M, Shibuta K, et al. Development of a new chemiluminescent enzyme immunoassay using a two-step sandwich method for measuring aldosterone concentrations. Diagnostics. 2021;11:433.","journal-title":"Diagnostics"},{"key":"2351_CR14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","volume":"58","author":"T Nishikawa","year":"2011","unstructured":"Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, et al. Guidelines for the diagnosis and treatment of primary aldosteronism -The Japan Endocrine Society 2009. Endocr J. 2011;58:711.","journal-title":"Endocr J"},{"key":"2351_CR15","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1111\/jdi.13312","volume":"11","author":"M Okazaki-Hada","year":"2020","unstructured":"Okazaki-Hada M, Moriya A, Nagao M, Oikawa S, Fukuda I, Sugihara H. Different pathogenesis of glucose intolerance in two subtypes of primary aldosteronism: aldosterone-producing adenoma and idiopathic hyperaldosteronism. J Diabetes Investig. 2020;11:1511\u20139.","journal-title":"J Diabetes Investig"},{"key":"2351_CR16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL 3rd, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35\u201341.","journal-title":"Stroke"},{"key":"2351_CR17","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/jama.289.5.579","volume":"289","author":"K Reynolds","year":"2003","unstructured":"Reynolds K, Lewis B, Nolen JDL, Kinney GL, Sathya B, He J, et al. Alcohol consumption and risk of stroke: a meta-analysis. JAMA. 2003;289:579\u201388.","journal-title":"JAMA"},{"key":"2351_CR18","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1212\/WNL.0000000000000837","volume":"83","author":"J Staals","year":"2014","unstructured":"Staals J, Makin SDJ, Doubal FN, Dennis MS, Wardlaw JM. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology. 2014;83:1228\u201334.","journal-title":"Neurology"},{"key":"2351_CR19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk J, Alavi A, Hurtig H, Zimmerman R. MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. Am J Roentgenol. 1987;149:351\u20136.","journal-title":"Am J Roentgenol"},{"key":"2351_CR20","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822\u201338.","journal-title":"Lancet Neurol"},{"key":"2351_CR21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1474-4422(09)70013-4","volume":"8","author":"SM Greenberg","year":"2009","unstructured":"Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Salman RA-S, Warach S, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009;8:165\u201374.","journal-title":"Lancet Neurol"},{"key":"2351_CR22","doi-asserted-by":"crossref","first-page":"e1086","DOI":"10.1212\/WNL.0000000000007039","volume":"92","author":"Y Yakushiji","year":"2019","unstructured":"Yakushiji Y, Wilson D, Ambler G, Charidimou A, Beiser A, van Buchem MA, et al. Distribution of cerebral microbleeds in the East and West: individual participant meta-analysis. Neurology. 2019;92:e1086\u2013e1097.","journal-title":"Neurology"},{"key":"2351_CR23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.5853\/jos.2016.00360","volume":"18","author":"BJ Kim","year":"2016","unstructured":"Kim BJ, Yoon Y, Sohn H, Kang D-W, Kim JS, Kwon SU. Difference in the location and risk factors of cerebral microbleeds according to ischemic stroke subtypes. J Stroke. 2016;18:297\u2013303.","journal-title":"J Stroke"},{"key":"2351_CR24","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1136\/jnnp.2003.030858","volume":"75","author":"AMJ MacLullich","year":"2004","unstructured":"MacLullich AMJ, Wardlaw JM, Ferguson KJ, Starr JM, Seckl JR, Deary IJ. Enlarged perivascular spaces are associated with cognitive function in healthy elderly men. J Neurol Neurosurg Psychiatry. 2004;75:1519.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2351_CR25","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","volume":"159","author":"G Zou","year":"2004","unstructured":"Zou G. A Modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159:702\u20136.","journal-title":"Am J Epidemiol"},{"key":"2351_CR26","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1355398","volume":"15","author":"J McCarthy","year":"2024","unstructured":"McCarthy J, Munnings M, Clissold B, Fuller PJ, Yang J, Phan TG. Prevalence of primary aldosteronism in acute stroke or transient ischemic attack: a systematic review and meta-analysis. Front Endocrinol. 2024;15:1355398.","journal-title":"Front Endocrinol"},{"key":"2351_CR27","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41440-023-01458-w","volume":"47","author":"B-C Lee","year":"2024","unstructured":"Lee B-C, Tsai H-H, Chen Z-W, Chang C-C, Huang J-Z, Chang Y-Y, et al. Aldosteronism is associated with more severe cerebral small vessel disease in hypertensive intracerebral hemorrhage. Hypertens Res. 2024;47:608\u201317.","journal-title":"Hypertens Res"},{"key":"2351_CR28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.brainres.2016.02.034","volume":"1637","author":"QN Dinh","year":"2016","unstructured":"Dinh QN, Young MJ, Evans MA, Drummond GR, Sobey CG, Chrissobolis S. Aldosterone-induced oxidative stress and inflammation in the brain are mediated by the endothelial cell mineralocorticoid receptor. Brain Res. 2016;1637:146\u201353.","journal-title":"Brain Res"},{"key":"2351_CR29","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.3390\/ijms20205214","volume":"20","author":"Z-W Chen","year":"2019","unstructured":"Chen Z-W, Tsai C-H, Pan C-T, Chou C-H, Liao C-W, Hung C-S, et al. Endothelial dysfunction in primary aldosteronism. Int J Mol Sci. 2019;20:5214.","journal-title":"Int J Mol Sci"},{"key":"2351_CR30","doi-asserted-by":"crossref","unstructured":"Hattori Y, Imada S, Usui R, Yamamoto A, Nakamura M, Ihara M. High middle cerebral artery wall shear stress in branch atheromatous disease: a computational fluid dynamics analysis. J Atheroscler Thromb. 2025;32:994\u20131005.","DOI":"10.5551\/jat.65439"},{"key":"2351_CR31","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jamaneurol.2018.1073","volume":"75","author":"RW Regenhardt","year":"2018","unstructured":"Regenhardt RW, Das AS, Lo EH, Caplan LR. Advances in understanding the pathophysiology of lacunar stroke: a review. JAMA Neurol. 2018;75:1273.","journal-title":"JAMA Neurol"},{"key":"2351_CR32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1212\/WNL.56.5.673","volume":"56","author":"P Verpillat","year":"2001","unstructured":"Verpillat P, Alp\u00e9rovitch A, Cambien F, Besan\u00e7on V, Desal H, Tzourio C. Aldosterone synthase (CYP11B2) gene polymorphism and cerebral white matter hyperintensities. Neurology. 2001;56:673\u20135.","journal-title":"Neurology"},{"key":"2351_CR33","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/jnnp-2014-309685","volume":"87","author":"T Tran","year":"2016","unstructured":"Tran T, Cotlarciuc I, Yadav S, Hasan N, Bentley P, Levi C, et al. Candidate-gene analysis of white matter hyperintensities on neuroimaging. J Neurol Neurosurg Psychiatry. 2016;87:260.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2351_CR34","doi-asserted-by":"publisher","unstructured":"Lee SM, Choi YJ, Lee K, Kim HK, Park J-S, Lim YC, et al. Pearls & Oy-sters: cerebral microbleeds caused by adrenocortical adenoma-related primary aldosteronism. Neurology. 2021;96: https:\/\/doi.org\/10.1212\/WNL.0000000000011934.","DOI":"10.1212\/WNL.0000000000011934"},{"key":"2351_CR35","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1474-4422(23)00131-X","volume":"22","author":"M Duering","year":"2023","unstructured":"Duering M, Biessels GJ, Brodtmann A, Chen C, Cordonnier C, de Leeuw F-E, et al. Neuroimaging standards for research into small vessel disease\u2014advances since 2013. Lancet Neurol. 2023;22:602\u201318.","journal-title":"Lancet Neurol"},{"key":"2351_CR36","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3390\/biomedicines12071463","volume":"12","author":"MR Hayden","year":"2024","unstructured":"Hayden MR. Cerebral microbleeds associate with brain endothelial cell activation-dysfunction and blood\u2013brain barrier dysfunction\/disruption with increased risk of hemorrhagic and ischemic stroke. Biomedicines. 2024;12:1463.","journal-title":"Biomedicines"},{"key":"2351_CR37","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/jhh.2010.65","volume":"24","author":"Z \u0160oml\u00f3ov\u00e1","year":"2010","unstructured":"\u0160oml\u00f3ov\u00e1 Z, Widimsk\u00fd J, Rosa J, Wichterle D, \u0160trauch B, Petr\u00e1k O, et al. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism. J Hum Hypertens. 2010;24:625\u201330.","journal-title":"J Hum Hypertens"},{"key":"2351_CR38","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/ajh\/hpw003","volume":"29","author":"W Kawarazaki","year":"2016","unstructured":"Kawarazaki W, Fujita T. The role of aldosterone in obesity-related hypertension. Am J Hypertens. 2016;29:415\u201323.","journal-title":"Am J Hypertens"},{"key":"2351_CR39","doi-asserted-by":"crossref","first-page":"F1670","DOI":"10.1152\/ajprenal.00391.2018","volume":"315","author":"KB Assersen","year":"2018","unstructured":"Assersen KB, Jensen PS, Briones AM, Rasmussen LM, Marcussen N, Toft A, et al. Periarterial fat from two human vascular beds is not a source of aldosterone to promote vasoconstriction. Am J Physiol-Ren Physiol. 2018;315:F1670\u2013F1682.","journal-title":"Am J Physiol-Ren Physiol"},{"key":"2351_CR40","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1530\/EC-21-0057","volume":"10","author":"D Watanabe","year":"2021","unstructured":"Watanabe D, Morimoto S, Morishima N, Ichihara A. Clinical impacts of endothelium-dependent flow-mediated vasodilation assessment on primary aldosteronism. Endocr Connect. 2021;10:578\u201387.","journal-title":"Endocr Connect"},{"key":"2351_CR41","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/HJH.0000000000001989","volume":"37","author":"S Kishimoto","year":"2019","unstructured":"Kishimoto S, Oki K, Maruhashi T, Kajikawa M, Matsui S, Hashimoto H, et al. Eplerenone improves endothelial function and arterial stiffness and inhibits Rho-associated kinase activity in patients with idiopathic hyperaldosteronism. J Hypertens. 2019;37:1083\u201395.","journal-title":"J Hypertens"},{"key":"2351_CR42","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s42155-021-00220-y","volume":"4","author":"KB Quencer","year":"2021","unstructured":"Quencer KB. Adrenal vein sampling: technique and protocol, a systematic review. CVIR Endovasc. 2021;4:38.","journal-title":"CVIR Endovasc"},{"key":"2351_CR43","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/jnnp-2016-315324","volume":"88","author":"S Hilal","year":"2017","unstructured":"Hilal S, Mok V, Youn YC, Wong A, Ikram MK, Chen CLH, et al. Prevalence, risk factors and consequences of cerebral small vessel diseases: data from three Asian countries. J Neurol Neurosurg Psychiatry. 2017;88:669\u201374.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02351-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02351-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02351-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:02:22Z","timestamp":1762297342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02351-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2351"],"URL":"https:\/\/doi.org\/10.1038\/s41440-025-02351-4","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Motohiro Okumura reports no disclosures. Takeo Sato reports lecture fees from Pfizer Japan Inc. outside the submitted work. Yuki Tsujimoto reports no disclosures. Kenji Yamashiro subsidies from Teijin Pharma Ltd. and Ono Pharmaceutical Co. outside the submitted work. Yui Watanabe reports no disclosures. Satoshi Matsushima reports no disclosures. Tetsuya Shimizu reports no disclosures. Taku Gomi reports no disclosures. Hideto Kuribayashi reports no disclosures. Teppei Komatsu reports no disclosures. Kenichi Sakuta reports no disclosures. Kenichiro Sakai reports no disclosures. Hidetaka Mitsumura reports no disclosures. Yasuyuki Iguchi reports speaker honoraria from Abbvie, Alexion, Amgen, Biogen, Bristol Myers Squibb, Chugai, CSL-Behring, Daiichi-Sankyo, Eisai, Fujimoto Pharma, JB, Mitsubishi-Tanabe, Novartis, Otsuka, Pfizer, Sumitomo Dainippon, and Takeda, and his research is supported from B\u00f6ehringer-Ingelheim, Fujimoto Pharma, Chugai, JB Daiichi-Sankyo, Mitsubishi-Tanabe, Medical Concierge Co., Ltd., NAGATANIEN Co., Ltd., Shionogi, and Otsuka. outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"During the preparation of this work the authors used ChatGPT in order to improve readability and language. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of Generative AI and AI-assisted technologies in the writing process"}}]}}